📄 Redirect examination of Bradley Popovich (2 of 2) — Thursday, January 16, 1997
Address:
C:\DEPT103\CIVIL\1997\JAN\16\REDIRECT-EXAMINATION-OF-BRADLE.DOC
TRIAL
▲ Day 43 of 57

Redirect examination of Bradley Popovich (2 of 2)

Witness: Bradley Popovich
Examiner: Tom Lambert
Called by: Plaintiff • Date: Thursday, January 16, 1997 • Utterances: 64
On redirect, plaintiff's attorney Lambert rehabilitated Dr. Popovich's testimony about PCR/DQ Alpha testing, focusing on contamination claims raised during cross-examination. Popovich explained that the 1.3 allele anomaly seen in Item 52 was cross-hybridization, not contamination, supported by a repeated test and Cellmark's matching results. He defended the labs' handling standards as equal to or exceeding medical diagnostic labs.
1 A:

Good afternoon.

2 Q:

You were asked some questions on cross-examination about the reference -- the victim's reference strips, the DQ Alpha strips, and the polymarker strips?

3 A:

Yes, I was.

4 Q:

Did you have an opportunity to review those strips as part of your examination of materials in this case?

5 A:

I did.

6 Q:

Did you see any evidence of contamination on those strips?

7 A:

I did not.

8 Q:

The -- The items that were pointed out to you in cross-examination that Mr. Baker asked you about, whether those were the same alleles as Mr. Simpson had in his blood, in your view, did those alleles show any evidence at all of contamination of Mr. Simpson's blood with the reference vial?

9 A:

I see no reason to believe that those were derived from Mr. Simpson's reference file.

10 Q:

What is the scientific explanation for those segments that you saw?

11 A:

Well, the scientific explanation is that one has to look at the sequence, which things were performed, and if, in fact, Mr. Simpson's blood from -- from the vial was to have contaminated those, then there are many steps, controls, that would have been processed simultaneously that would also exhibit contamination. And the fact that not -- not just one, but all of those, uniformly show absolutely no evidence of contamination, allows one to make very, very subjective judgments and be very objective about what they're seeing. And there's no evidence at all, because all those controls are negative, that any of that could be due to contamination.

12 Q:

Incidentally, Doctor, where were the Fitzco cards for the reference -- for the victim's reference strips, where were those prepared?

13 A:

For the victims, it was in a completely separate part of the lab from where the processing of the stains was done. Part of the lab was called the evidence processing room; that's where the processing of all the samples, with the exception of the two victims' samples, were processed. They were processed in a separate lab called the serology lab, which is physically within the same building, but completely separated. There's absolutely -- I mean it's incomprehensible that there could be any contamination between those two reference vials of the victims and any of the other evidence.

14 Q:

You were also asked some questions about Item 52, the Department of Justice's DQ Alpha strip for that item. Again, did you see any evidence of contamination in that item?

15 A:

No, I did not.

16 Q:

These hints or traces of a 1.3 allele; what are those in effect, Doctor?

17 A:

Well, the 1.3 that's seen -- might it be helpful to look at the board?

18 Q:

Sure. It's right inside here. I think I can get it quickly.

19 MR. LAMBERT:

I thought I could get it but it's --

MR. P. BAKER: Putting up on the board, Civil 1281. (Exhibit 1281 displayed.)

20 A:

Here we go. Okay.

21 Q:

And you were about to explain this 1.3 issue in regard to Item 52?

22 A:

Yes. Relating to that and what is depicted in this particular figure, you could see at the top that there is a -- it says Item 52, and at the bottom it also says 52. What ended up happening at the Department of Justice, if we look at the column to -- to the right of the strips where the actual results are indicated, it says at the top, 1.2 -- I'm sorry, 1.1, 1.3. And then below that 1.3 with a trace. And then at the very bottom it says 1.1, 1.2, 1.3, very faint trace. Now, what, in fact, happened was when 52 was originally done, it was -- the top strip, it was -- it's one at the top of that figure. And what the analysts realized in looking at that was that there was -- in fact, that the 1.3 that is depicted there --

MR. P. BAKER: Objection, speculation, no foundation.

23 THE COURT:

Overruled.

24 A:

What they realized is that the 1.3 that was there could be due to -- reasons having to do with cross-hybridization. What they then did was to redo the hybridization for that, which is at the bottom, and that is a separate strip. It was repeated. I mean they did exactly what one would do in a situation where there was a question about the validity of this particular piece of evidence. They repeated it and they got the result at the bottom. What one can see at the bottom is that 1.3 essentially goes away when they repeated it. What that indicates -- that's a very, very strong indication that what we're dealing with here is cross-hybridization. Furthermore, it's a 1.1, 1.2 genotype; the prominent type. The significance of it being a 1.3 is paramount as giving this cross reaction. And the reason is that the -- the difference between the 1.2 and the 1.3 is a single base pair in that sequence. So the discrimination -- this is testing the ultimate ability of this test to discriminate between a 1.2 and a 1.3, and because there's a lot of DNA, it has led to this cross-hybridization. It's completely logical in terms of one being able to look at this and be very objective about looking at all the data, especially the fact that it was repeated, in being able to make that judgment.

25 Q:

And this evidence Item 52, was it also tested by Cellmark Laboratory?

26 A:

It was.

27 Q:

What were their results?

28 A:

They were the same.

29 Q:

So their results matched the 1.1, 1.2, that Department of Justice called in regard to this item?

30 A:

That's correct.

31 Q:

Does that give you further comfort that this is simply cross-hybridization that's being seen here?

32 A:

That's exactly what it says to me.

33 Q:

Now, you were also asked some questions about Colin Yamauchi's handling of the reference vial. Did you see any problems at all in the way Colin Yamauchi handled Mr. Simpson's reference vial in doing the sampling in this case?

MR. P. BAKER: Asked and answered.

34 THE COURT:

Overruled.

35 A:

I see no problem whatsoever with the way it was handled.

36 Q:

(BY MR. LAMBERT) Mr. Baker asked you some questions about the approximately 3,000 nanograms of DNA that were on the socks.

MR. P. BAKER: 1300.

37 Q:

I'm sorry, 1300 nanograms of DNA on the socks. Is that an amount of DNA that's consistent with the blood being splattered on the socks at the time of the crime?

38 A:

It's possible.

39 Q:

Now, you were also asked some questions -- Mr. Baker asked you some questions about transferring of DNA from one hand to another. Do you remember that you put it on one hand?

40 A:

Yes.

41 Q:

Is it important for laboratories to establish controls to ensure such transfers don't occur?

42 A:

Yes.

43 Q:

Did the laboratories testing here have such controls in place?

44 A:

Yes, they do.

45 Q:

Do you see any problems whatsoever in their test results in this case as a result of any such transfers?

46 A:

I do not. And even to just go a step farther -- I mean it's important to point out that the standards that were -- which were used in all three of these labs, and their handling of these particular items, is equal to, if not exceeding, the standards that are used in medical diagnostic labs in making important decisions regarding people's health, regarding DN

47 A:

It's no different. And the standards were equally -- equal to, if not exceeding, that in the medical world.

48 Q:

Mr. Baker, talking about evidence -- Item 31, asked you some questions about subjectivity and PCR testing. And you said that occasionally there is some subjectivity involved in making judgments about those tests. How is that subjective judgment exercised by the people doing these DQ Alpha strips?

49 A:

Well, it's based on experience and it's based on being objective in terms of looking at all the data. So it would be -- one needs to look at everything that took place in a series of experiments where one is -- where this is a part of that. And one needs to look at -- be very objective, look at all this data in terms of drawing conclusions, just as I did with No. 52, and what I call cross-hybridization. And the subjectivity is based on that experience and being objective and looking at all the data that one has to rely on. And again, I need to stress to you that oftentimes we have to do this and we have to look at this data and make subjective calls. And in the medical world, and I'm not trying to overdramatize it, we make life and death decisions based on this. At times you have to do it, and you have to look at all the cards on the table, and you have to make your best judgment based on all the facts. And that's what I believe was done here, and I believe that they did it accurately.

50 Q:

And in your view, did Gary Sims and Robin Cotton have the kind of experience and background that enables them to make those subjective judgments?

MR. P. BAKER: Irrelevant, argumentative.

51 THE COURT:

Overruled.

52 A:

Absolutely.

53 Q:

(BY MR. LAMBERT) In regard to most of the PCR test results in this case, was the subjective judgment call even necessary, Dr. Popovich?

54 A:

For the vast majority, not at all, it was very straightforward.

55 Q:

Finally, you were asked some questions about the relatively small number of nanograms in the Bundy blood drops. Do you remember those questions?

56 A:

Yes.

57 Q:

Is it uncommon in your experience in criminal cases for there to be a relatively low number of nanograms in evidence items?

58 A:

Not at all.

59 Q:

Does that prevent them from being tested accurately?

60 A:

As long as there is an amount that exceeds the threshold of the sensitivity of that task, it can be done and the results can be accurate.

61 Q:

In regard to all Bundy blood drops, were they above that threshold?

62 A:

The ones that yielded results were above that threshold, yes.

63 MR. LAMBERT:

No further questions, Your Honor. RECROSS-EXAMINATION BY MR. P. BAKER:

64 Q:

Did you ever go over the question that Mr. Lambert was going to ask you over lunch?

Temperature

procedural

Key Quotes (4)

Witness
The fact that not -- not just one, but all of those, uniformly show absolutely no evidence of contamination, allows one to make very, very subjective judgments and be very objective about what they're seeing.
Core rebuttal to contamination theory — argues that uniform negative controls across all samples rules out Simpson's reference vial as a contaminant.
Witness
It's incomprehensible that there could be any contamination between those two reference vials of the victims and any of the other evidence.
Emphatic dismissal of cross-contamination possibility based on physical separation of evidence processing rooms.
Witness
What one can see at the bottom is that 1.3 essentially goes away when they repeated it. What that indicates -- that's a very, very strong indication that what we're dealing with here is cross-hybridization.
Key technical explanation neutralizing Baker's cross-examination point about the 1.3 allele in Item 52.
Witness
The standards that were -- which were used in all three of these labs... is equal to, if not exceeding, the standards that are used in medical diagnostic labs in making important decisions regarding people's health.
Attempts to elevate jury's perception of lab rigor by comparing to trusted medical context.

Evidence (5)

Civil 1281
Board/figure displaying DQ Alpha strip results for Item 52, showing original and repeated hybridization results including the 1.3 allele issue
displayed and discussed
Informal
Item 52 — DQ Alpha strip from Department of Justice showing 1.3 allele cross-hybridization issue
discussed
Informal
Socks (Item referenced) — approximately 1300 nanograms of DNA; Baker corrected Lambert's misstatement of 3000 nanograms
discussed
Informal
Bundy blood drops — discussed in context of low nanogram quantities and testing threshold
discussed
Informal
Item 31 — referenced in context of subjectivity in PCR testing
discussed

Notable Exchanges (2)

LambertP. Baker
Lambert misstated the nanogram count on the socks as 'approximately 3,000' and Baker interjected from the floor to correct him to '1300,' which Lambert accepted.
strategic
P. BakerJudge Fujisaki
Baker objected three times during redirect — speculation/foundation, asked and answered, irrelevant/argumentative — all three overruled, suggesting aggressive but unsuccessful resistance to rehabilitation.
heated

Light Moments (1)

Lambert
Lambert tries to retrieve Exhibit 1281 quickly, fumbles: 'I thought I could get it but it's --' before managing to display it.

Credibility Attacks (2)

⚔ Colin Yamauchi
prior examination / rehabilitated on redirect
Baker had raised questions about Yamauchi's handling of Simpson's reference vial on cross; Lambert asked Popovich on redirect if he saw any problems, and Popovich said 'I see no problem whatsoever.'
⚔ Gary Sims / Robin Cotton
competence challenge (Baker) vs. endorsement (Lambert)
Baker had challenged the subjectivity in PCR calls; Lambert asked directly whether Sims and Cotton had the experience to make those calls. Popovich answered 'Absolutely' over Baker's objection.

Witness Demeanor

(Exhibit 1281 displayed.) -- witness redirects explanation to the board

Objections

3 objections (0 sustained, 3 overruled)
Proceeding 8828 • 64 utterances • Plaintiff witness
Civil Trial
Department 103
⚖️ Start
📂 JAN 16, 1997 📄 Redirect examination of Bradle
JAN 16, 1997 KRT DvH TD